Steven Osborn
Family Medicine · Omaha, NENPI 1104935006
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.8% of the total across 197 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 30 manufacturers, the largest accounting for just 19.3% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $1,256 and has fallen 83.6% since, to $205 in 2022.
Across 197 payments — averaging $14.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$541
- AstraZeneca$425
- AbbVie$396
- Amgen$310
- Boehringer Ingelheim$126
- GSK$124
- plus $885 from 24 others
What the payments were for
- Food & beverage$2,800100%
- Education$60%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 49 | $541 |
| AstraZeneca | 14 | $425 |
| AbbVie(2 entities) | 24 | $396 |
| Amgen | 23 | $310 |
| Boehringer Ingelheim | 10 | $126 |
| GSK | 14 | $124 |
| Sanofi-aventis U.S. LLC | 7 | $119 |
| Merck | 6 | $76 |
| Lilly USA, LLC | 6 | $74 |
| Upsher-smith Laboratories LLC | 4 | $72 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $65 |
| Pfizer | 5 | $64 |
| Antares Pharma, Inc. | 3 | $51 |
| Amarin Pharma, Inc. | 3 | $45 |
| Johnson & Johnson | 3 | $41 |
| Eisai Inc. | 3 | $40 |
| Novartis | 3 | $40 |
| Kowa Pharmaceuticals America, Inc. | 2 | $24 |
| Adlon Therapeutics L.p. | 1 | $18 |
| Ironwood Pharmaceuticals, Inc | 1 | $18 |
| Astellas Pharma US Inc | 1 | $15 |
| Dexcom, Inc. | 1 | $15 |
| Ironshore Pharmaceuticals Inc. | 1 | $15 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $15 |
| Ultragenyx Pharmaceutical Inc. | 1 | $14 |
| E.r. Squibb & Sons, L.L.C. | 1 | $13 |
| Teva Pharmaceuticals USA, Inc. | 1 | $13 |
| Nestle Healthcare Nutrition Inc. | 1 | $13 |
| Jazz Pharmaceuticals Inc. | 1 | $12 |
| Genentech USA, Inc. | 1 | $11 |
How this compares
$2,806 in reported general payments places this provider in the 80th percentile of 981 family medicine providers in Nebraska.
Other family medicine in Omaha
- Gerard StanleyOmaha$50K
- Yongge LiuOmaha$15K
- M DadaOmaha$14K
- Christopher ConnollyOmaha$12K
- Paul VanaOmaha$12K
- Stephen TetraultOmaha$11K
- James RamigOmaha$11K
- Jeffrey RappOmaha$10K
- Christine Carlson RahnOmaha$10K
- Joseph DumbaOmaha$10K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.